Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May 1;38(3):233-240.
doi: 10.1097/HCO.0000000000001033. Epub 2023 Mar 1.

Considerations for specific cardiomyopathies during pregnancy

Madeline Abrams  1 , Ella Magun, Ersilia M DeFilippis
Affiliations
Review

Considerations for specific cardiomyopathies during pregnancy

Madeline Abrams et al. Curr Opin Cardiol. .

Abstract

Purpose of review: Maternal mortality in the United States continues to increase. Cardiovascular disease, and in particular, cardiomyopathy and heart failure, serves as one of the principal causes of pregnancy-related mortality. The goal of this review is to summarize current knowledge on various cardiomyopathies in pregnancy, with an emphasis on cardiomyopathies beyond the most common in pregnancy, peripartum cardiomyopathy.

Recent findings: Although existing literature is somewhat limited, outcome studies of cardiomyopathy in pregnancy have demonstrated increased risk for adverse cardiovascular events and maternal morbidity and mortality. Herein, we review and synthesize recent studies focusing on preconception risk and counseling, pharmacologic management, and maternal outcomes in various cardiomyopathies during pregnancy including: dilated cardiomyopathy, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, noncompaction cardiomyopathy, and chemotherapy-induced cardiomyopathy.

Summary: In an effort to optimize maternal outcomes, it is critical to recognize the risk associated with various cardiomyopathies in pregnancy and understand the tools for risk stratification and antepartum management. Further research on less common cardiomyopathies in pregnancy is warranted to provide more standardized recommendations.

PubMed Disclaimer

References

    1. Mehta LS, Warnes CA, Bradley E, et al. Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association. Circulation 2020; 141:e884–e903.
    1. Pregnancy Mortality Surveillance System. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mort... [cited December 10, 2022].
    1. Magun E, DeFilippis EM, Noble S, et al. Cardiovascular care for pregnant women with cardiovascular disease. J Am Coll Cardiol 2020; 76:2102–2113.
    1. Davis MB, Arendt K, Bello NA, et al. Team-based care of women with cardiovascular disease from pre-conception through pregnancy and postpartum. J Am Coll Cardiol 2021; 77:1763–1777.
    1. Ukah UV, Dayan N, Potter BJ, et al. Severe maternal morbidity and long-term risk of cardiovascular hospitalization. Circ Cardiovasc Qual Outcomes 2022; 15:e008393.

MeSH terms